More on MLYS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (5/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mineralys Therapeutics (NQ:MLYS)
Delayed: 26.59 -0.13 (0.49%)
Prev. Close $26.72  
Open$26.22 
52 Wk High$ 
52 Wk Low$ 
Day High$27.07 
Day Low$25.66 
P/E N/A  
EPS$ 
Volume1,343,197 

Friends, Peers and Foes (?): AZN, BIIB, AMGN, IRON, JNJ (more...)

Mar 4, 2026 07:25 PM Form 3 Mineralys Therapeutics, For: Mar 04 Filed by: Warren Eric
Mar 3, 2026 05:31 PM Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Feb 26, 2026 04:05 PM Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Feb 20, 2026 07:50 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: Shah Rajeev M.
Feb 20, 2026 07:48 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: Congleton Jon
Feb 20, 2026 07:48 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: SBLENDORIO GLENN
Feb 20, 2026 07:47 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: Gold Alexander M
Feb 20, 2026 07:47 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: Karydas Daphne
Feb 20, 2026 07:47 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: Slingsby Brian Taylor
Feb 20, 2026 07:47 PM Form 4 Mineralys Therapeutics, For: Feb 19 Filed by: AKKARAJU SRINIVAS
View All Articles

Entities mentioned with MLYS

View All Entities